🇺🇸 FDA
Pipeline program

GHB11L1

GHB-CS07

Phase 2 mab completed

Quick answer

GHB11L1 for Influenza, Human is a Phase 2 program (mab) at Atea Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Atea Pharmaceuticals
Indication
Influenza, Human
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials